img

Global Dry Eye Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dry Eye Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Dry Eye Disease Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dry Eye Disease Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dry Eye Disease Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Other

Segment by Application


Hospital
Retail Pharmacy
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dry Eye Disease Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dry Eye Disease Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dry Eye Disease Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dry Eye Disease Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dry Eye Disease Drug introduction, etc. Dry Eye Disease Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dry Eye Disease Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Dry Eye Disease Drug Market Overview
1.1 Dry Eye Disease Drug Product Overview
1.2 Dry Eye Disease Drug Market Segment by Type
1.2.1 Artificial Tears
1.2.2 Anti-inflammatory Drugs
1.2.3 Other
1.3 Global Dry Eye Disease Drug Market Size by Type
1.3.1 Global Dry Eye Disease Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Dry Eye Disease Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Dry Eye Disease Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dry Eye Disease Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Dry Eye Disease Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Dry Eye Disease Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Dry Eye Disease Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Dry Eye Disease Drug Sales Breakdown by Type (2018-2024)
2 Global Dry Eye Disease Drug Market Competition by Company
2.1 Global Top Players by Dry Eye Disease Drug Sales (2018-2024)
2.2 Global Top Players by Dry Eye Disease Drug Revenue (2018-2024)
2.3 Global Top Players by Dry Eye Disease Drug Price (2018-2024)
2.4 Global Top Manufacturers Dry Eye Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dry Eye Disease Drug Market Competitive Situation and Trends
2.5.1 Dry Eye Disease Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Dry Eye Disease Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dry Eye Disease Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Dry Eye Disease Drug Market
2.8 Key Manufacturers Dry Eye Disease Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dry Eye Disease Drug Status and Outlook by Region
3.1 Global Dry Eye Disease Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Dry Eye Disease Drug Historic Market Size by Region
3.2.1 Global Dry Eye Disease Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Dry Eye Disease Drug Sales in Value by Region (2018-2024)
3.2.3 Global Dry Eye Disease Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Dry Eye Disease Drug Forecasted Market Size by Region
3.3.1 Global Dry Eye Disease Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Dry Eye Disease Drug Sales in Value by Region (2024-2029)
3.3.3 Global Dry Eye Disease Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Dry Eye Disease Drug by Application
4.1 Dry Eye Disease Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Retail Pharmacy
4.1.3 Others
4.2 Global Dry Eye Disease Drug Market Size by Application
4.2.1 Global Dry Eye Disease Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Dry Eye Disease Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Dry Eye Disease Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dry Eye Disease Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Dry Eye Disease Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Dry Eye Disease Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Dry Eye Disease Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Dry Eye Disease Drug Sales Breakdown by Application (2018-2024)
5 North America Dry Eye Disease Drug by Country
5.1 North America Dry Eye Disease Drug Historic Market Size by Country
5.1.1 North America Dry Eye Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Dry Eye Disease Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Dry Eye Disease Drug Sales in Value by Country (2018-2024)
5.2 North America Dry Eye Disease Drug Forecasted Market Size by Country
5.2.1 North America Dry Eye Disease Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Dry Eye Disease Drug Sales in Value by Country (2024-2029)
6 Europe Dry Eye Disease Drug by Country
6.1 Europe Dry Eye Disease Drug Historic Market Size by Country
6.1.1 Europe Dry Eye Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Dry Eye Disease Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Dry Eye Disease Drug Sales in Value by Country (2018-2024)
6.2 Europe Dry Eye Disease Drug Forecasted Market Size by Country
6.2.1 Europe Dry Eye Disease Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Dry Eye Disease Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Dry Eye Disease Drug by Region
7.1 Asia-Pacific Dry Eye Disease Drug Historic Market Size by Region
7.1.1 Asia-Pacific Dry Eye Disease Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Dry Eye Disease Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Dry Eye Disease Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Dry Eye Disease Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Dry Eye Disease Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Dry Eye Disease Drug Sales in Value by Region (2024-2029)
8 Latin America Dry Eye Disease Drug by Country
8.1 Latin America Dry Eye Disease Drug Historic Market Size by Country
8.1.1 Latin America Dry Eye Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Dry Eye Disease Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Dry Eye Disease Drug Sales in Value by Country (2018-2024)
8.2 Latin America Dry Eye Disease Drug Forecasted Market Size by Country
8.2.1 Latin America Dry Eye Disease Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Dry Eye Disease Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Dry Eye Disease Drug by Country
9.1 Middle East and Africa Dry Eye Disease Drug Historic Market Size by Country
9.1.1 Middle East and Africa Dry Eye Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Dry Eye Disease Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Dry Eye Disease Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Dry Eye Disease Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Dry Eye Disease Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Dry Eye Disease Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Allergan
10.1.1 Allergan Company Information
10.1.2 Allergan Introduction and Business Overview
10.1.3 Allergan Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Allergan Dry Eye Disease Drug Products Offered
10.1.5 Allergan Recent Development
10.2 Alcon
10.2.1 Alcon Company Information
10.2.2 Alcon Introduction and Business Overview
10.2.3 Alcon Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Alcon Dry Eye Disease Drug Products Offered
10.2.5 Alcon Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis Dry Eye Disease Drug Products Offered
10.3.5 Novartis Recent Development
10.4 Santen Pharma
10.4.1 Santen Pharma Company Information
10.4.2 Santen Pharma Introduction and Business Overview
10.4.3 Santen Pharma Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Santen Pharma Dry Eye Disease Drug Products Offered
10.4.5 Santen Pharma Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Information
10.5.2 Johnson & Johnson Introduction and Business Overview
10.5.3 Johnson & Johnson Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Johnson & Johnson Dry Eye Disease Drug Products Offered
10.5.5 Johnson & Johnson Recent Development
10.6 Bausch & Lomb
10.6.1 Bausch & Lomb Company Information
10.6.2 Bausch & Lomb Introduction and Business Overview
10.6.3 Bausch & Lomb Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Bausch & Lomb Dry Eye Disease Drug Products Offered
10.6.5 Bausch & Lomb Recent Development
10.7 Thea pharmaceuticals
10.7.1 Thea pharmaceuticals Company Information
10.7.2 Thea pharmaceuticals Introduction and Business Overview
10.7.3 Thea pharmaceuticals Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Thea pharmaceuticals Dry Eye Disease Drug Products Offered
10.7.5 Thea pharmaceuticals Recent Development
10.8 URSAPHARM
10.8.1 URSAPHARM Company Information
10.8.2 URSAPHARM Introduction and Business Overview
10.8.3 URSAPHARM Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 URSAPHARM Dry Eye Disease Drug Products Offered
10.8.5 URSAPHARM Recent Development
10.9 SIMILASAN
10.9.1 SIMILASAN Company Information
10.9.2 SIMILASAN Introduction and Business Overview
10.9.3 SIMILASAN Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 SIMILASAN Dry Eye Disease Drug Products Offered
10.9.5 SIMILASAN Recent Development
10.10 Akorn
10.10.1 Akorn Company Information
10.10.2 Akorn Introduction and Business Overview
10.10.3 Akorn Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Akorn Dry Eye Disease Drug Products Offered
10.10.5 Akorn Recent Development
10.11 United Laboratories
10.11.1 United Laboratories Company Information
10.11.2 United Laboratories Introduction and Business Overview
10.11.3 United Laboratories Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 United Laboratories Dry Eye Disease Drug Products Offered
10.11.5 United Laboratories Recent Development
10.12 Sun Pharmaceutical
10.12.1 Sun Pharmaceutical Company Information
10.12.2 Sun Pharmaceutical Introduction and Business Overview
10.12.3 Sun Pharmaceutical Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Sun Pharmaceutical Dry Eye Disease Drug Products Offered
10.12.5 Sun Pharmaceutical Recent Development
10.13 Jianfeng Group
10.13.1 Jianfeng Group Company Information
10.13.2 Jianfeng Group Introduction and Business Overview
10.13.3 Jianfeng Group Dry Eye Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Jianfeng Group Dry Eye Disease Drug Products Offered
10.13.5 Jianfeng Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dry Eye Disease Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dry Eye Disease Drug Industrial Chain Analysis
11.4 Dry Eye Disease Drug Market Dynamics
11.4.1 Dry Eye Disease Drug Industry Trends
11.4.2 Dry Eye Disease Drug Market Drivers
11.4.3 Dry Eye Disease Drug Market Challenges
11.4.4 Dry Eye Disease Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dry Eye Disease Drug Distributors
12.3 Dry Eye Disease Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Artificial Tears
Table 2. Major Company of Anti-inflammatory Drugs
Table 3. Major Company of Other
Table 4. Global Dry Eye Disease Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Dry Eye Disease Drug Sales by Type (2018-2024) & (K Units)
Table 6. Global Dry Eye Disease Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Dry Eye Disease Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Dry Eye Disease Drug Market Share in Value by Type (2018-2024)
Table 9. Global Dry Eye Disease Drug Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Dry Eye Disease Drug Sales by Type (2024-2029) & (K Units)
Table 11. Global Dry Eye Disease Drug Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Dry Eye Disease Drug Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Dry Eye Disease Drug Sales Market Share in Value by Type (2024-2029)
Table 14. Global Dry Eye Disease Drug Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Dry Eye Disease Drug Sales by Type (2018-2024) & (K Units)
Table 16. North America Dry Eye Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Dry Eye Disease Drug Sales (K Units) by Type (2018-2024)
Table 18. Europe Dry Eye Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Dry Eye Disease Drug Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Dry Eye Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Dry Eye Disease Drug Sales (K Units) by Type (2018-2024)
Table 22. Latin America Dry Eye Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Dry Eye Disease Drug Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Dry Eye Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Dry Eye Disease Drug Sales by Company (2018-2024) & (K Units)
Table 26. Global Dry Eye Disease Drug Sales Share by Company (2018-2024)
Table 27. Global Dry Eye Disease Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Dry Eye Disease Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Dry Eye Disease Drug Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Dry Eye Disease Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Dry Eye Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dry Eye Disease Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Dry Eye Disease Drug Market
Table 34. Key Manufacturers Dry Eye Disease Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Dry Eye Disease Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Dry Eye Disease Drug Sales by Region (2018-2024) & (K Units)
Table 38. Global Dry Eye Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Dry Eye Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Dry Eye Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Dry Eye Disease Drug Sales by Region (2024-2029) & (K Units)
Table 43. Global Dry Eye Disease Drug Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Dry Eye Disease Drug Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Dry Eye Disease Drug Sales Market Share in Value by Region (2024-2029)
Table 46. Global Dry Eye Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Dry Eye Disease Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Dry Eye Disease Drug Sales by Application (2018-2024) & (K Units)
Table 49. Global Dry Eye Disease Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Dry Eye Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Dry Eye Disease Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Dry Eye Disease Drug Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Dry Eye Disease Drug Sales by Application (2024-2029) & (K Units)
Table 54. Global Dry Eye Disease Drug Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Dry Eye Disease Drug Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Dry Eye Disease Drug Sales Market Share in Value by Application (2024-2029)
Table 57. Global Dry Eye Disease Drug Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Dry Eye Disease Drug Sales by Application (2018-2024) (K Units)
Table 59. North America Dry Eye Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Dry Eye Disease Drug Sales by Application (2018-2024) (K Units)
Table 61. Europe Dry Eye Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Dry Eye Disease Drug Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Dry Eye Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Dry Eye Disease Drug Sales by Application (2018-2024) (K Units)
Table 65. Latin America Dry Eye Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Dry Eye Disease Drug Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Dry Eye Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Dry Eye Disease Drug Sales by Country (2018-2024) & (K Units)
Table 69. North America Dry Eye Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Dry Eye Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Dry Eye Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Dry Eye Disease Drug Sales by Country (2024-2029) & (K Units)
Table 73. North America Dry Eye Disease Drug Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Dry Eye Disease Drug Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Dry Eye Disease Drug Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Dry Eye Disease Drug Sales by Country (2018-2024) & (K Units)
Table 77. Europe Dry Eye Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Dry Eye Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Dry Eye Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Dry Eye Disease Drug Sales by Country (2024-2029) & (K Units)
Table 81. Europe Dry Eye Disease Drug Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Dry Eye Disease Drug Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Dry Eye Disease Drug Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Dry Eye Disease Drug Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Dry Eye Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Dry Eye Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Dry Eye Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Dry Eye Disease Drug Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Dry Eye Disease Drug Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Dry Eye Disease Drug Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Dry Eye Disease Drug Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Dry Eye Disease Drug Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Dry Eye Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Dry Eye Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Dry Eye Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Dry Eye Disease Drug Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Dry Eye Disease Drug Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Dry Eye Disease Drug Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Dry Eye Disease Drug Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Dry Eye Disease Drug Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Dry Eye Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Dry Eye Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Dry Eye Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Dry Eye Disease Drug Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Dry Eye Disease Drug Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Dry Eye Disease Drug Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Dry Eye Disease Drug Sales Market Share in Value by Country (2024-2029)
Table 108. Allergan Company Information
Table 109. Allergan Introduction and Business Overview
Table 110. Allergan Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Allergan Dry Eye Disease Drug Product
Table 112. Allergan Recent Development
Table 113. Alcon Company Information
Table 114. Alcon Introduction and Business Overview
Table 115. Alcon Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Alcon Dry Eye Disease Drug Product
Table 117. Alcon Recent Development
Table 118. Novartis Company Information
Table 119. Novartis Introduction and Business Overview
Table 120. Novartis Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Novartis Dry Eye Disease Drug Product
Table 122. Novartis Recent Development
Table 123. Santen Pharma Company Information
Table 124. Santen Pharma Introduction and Business Overview
Table 125. Santen Pharma Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Santen Pharma Dry Eye Disease Drug Product
Table 127. Santen Pharma Recent Development
Table 128. Johnson & Johnson Company Information
Table 129. Johnson & Johnson Introduction and Business Overview
Table 130. Johnson & Johnson Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Johnson & Johnson Dry Eye Disease Drug Product
Table 132. Johnson & Johnson Recent Development
Table 133. Bausch & Lomb Company Information
Table 134. Bausch & Lomb Introduction and Business Overview
Table 135. Bausch & Lomb Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Bausch & Lomb Dry Eye Disease Drug Product
Table 137. Bausch & Lomb Recent Development
Table 138. Thea pharmaceuticals Company Information
Table 139. Thea pharmaceuticals Introduction and Business Overview
Table 140. Thea pharmaceuticals Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Thea pharmaceuticals Dry Eye Disease Drug Product
Table 142. Thea pharmaceuticals Recent Development
Table 143. URSAPHARM Company Information
Table 144. URSAPHARM Introduction and Business Overview
Table 145. URSAPHARM Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. URSAPHARM Dry Eye Disease Drug Product
Table 147. URSAPHARM Recent Development
Table 148. SIMILASAN Company Information
Table 149. SIMILASAN Introduction and Business Overview
Table 150. SIMILASAN Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. SIMILASAN Dry Eye Disease Drug Product
Table 152. SIMILASAN Recent Development
Table 153. Akorn Company Information
Table 154. Akorn Introduction and Business Overview
Table 155. Akorn Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Akorn Dry Eye Disease Drug Product
Table 157. Akorn Recent Development
Table 158. United Laboratories Company Information
Table 159. United Laboratories Introduction and Business Overview
Table 160. United Laboratories Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. United Laboratories Dry Eye Disease Drug Product
Table 162. United Laboratories Recent Development
Table 163. Sun Pharmaceutical Company Information
Table 164. Sun Pharmaceutical Introduction and Business Overview
Table 165. Sun Pharmaceutical Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Sun Pharmaceutical Dry Eye Disease Drug Product
Table 167. Sun Pharmaceutical Recent Development
Table 168. Jianfeng Group Company Information
Table 169. Jianfeng Group Introduction and Business Overview
Table 170. Jianfeng Group Dry Eye Disease Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Jianfeng Group Dry Eye Disease Drug Product
Table 172. Jianfeng Group Recent Development
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Dry Eye Disease Drug Market Trends
Table 176. Dry Eye Disease Drug Market Drivers
Table 177. Dry Eye Disease Drug Market Challenges
Table 178. Dry Eye Disease Drug Market Restraints
Table 179. Dry Eye Disease Drug Distributors List
Table 180. Dry Eye Disease Drug Downstream Customers
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Dry Eye Disease Drug Product Picture
Figure 2. Global Dry Eye Disease Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Dry Eye Disease Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Dry Eye Disease Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Artificial Tears
Figure 6. Global Artificial Tears Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Anti-inflammatory Drugs
Figure 8. Global Anti-inflammatory Drugs Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Other
Figure 10. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Dry Eye Disease Drug Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Dry Eye Disease Drug Sales Market Share by Type in 2022 & 2029
Figure 13. North America Dry Eye Disease Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Dry Eye Disease Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Dry Eye Disease Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Dry Eye Disease Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Dry Eye Disease Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Dry Eye Disease Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Dry Eye Disease Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Dry Eye Disease Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Dry Eye Disease Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Dry Eye Disease Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Dry Eye Disease Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Dry Eye Disease Drug Revenue in 2022
Figure 25. Dry Eye Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Retail Pharmacy
Figure 29. Global Retail Pharmacy Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Dry Eye Disease Drug Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Dry Eye Disease Drug Sales Market Share by Application in 2022 & 2029
Figure 34. North America Dry Eye Disease Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Dry Eye Disease Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Dry Eye Disease Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Dry Eye Disease Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Dry Eye Disease Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Dry Eye Disease Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Dry Eye Disease Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Dry Eye Disease Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Dry Eye Disease Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Dry Eye Disease Drug Manufacturing Cost Structure
Figure 45. Dry Eye Disease Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries